Supermax Corporation Bhd (7106)
Kuala Lumpur Exchange · Malaysia · prices in MYR · close of 23 Oct 2026
Key indicators
| Last close | MYR 0.455 |
|---|---|
| 52-week range | 0.250 – 0.515 |
| Return, 1 month / 3 months | +15.2% / +68.5% |
| Return, 1 year / 3 years | −8.1% / −30.0% |
| Trend | Uptrend |
| RSI (14) | 60 |
| Volatility (1 year) | 55.3% |
| Worst drawdown (1 year) | -47.4% |
| Average daily value traded | 6.56M MYR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Supermax Corporation is a Malaysian maker of rubber gloves, producing examination gloves in nitrile and latex for medical, dental and industrial use. It sells under its own brands to hospitals, clinics, laboratories and distributors, and also supplies customers who buy gloves for food handling and cleaning work. The company is based in Malaysia, where it runs its manufacturing operations, and it ships its gloves to markets around the world.
The shares are listed on the Kuala Lumpur Exchange in Malaysia under the code 7106, and the price on this page is in Malaysian ringgit (MYR). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Supermax Corporation Bhd (7106) trades on the Kuala Lumpur Exchange in Malaysia. It last closed at MYR 0.455 on 23 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 226 of 1,066 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 8.1% and over the last three months it rose 68.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Kuala Lumpur Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 91 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 43.1% | ||
| From 52-week high | -9.0% | ||
| Momentum | 73 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 68.5% | ||
| 6-month return | 37.9% | ||
| 12-month return, skipping the last month | -20.2% | ||
| Stability (higher is calmer) | 26 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 55.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -47.4% | ||
| Liquidity | 92 · Strong | Trades actively. | |
| Average daily value traded | 6.56M MYR | ||
| Zero-volume days | 5.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +2.2% |
|---|---|
| 1 month | +15.2% |
| 3 months | +68.5% |
| 6 months | +37.9% |
| 1 year | −8.1% |
| 3 years | −30.0% |
| 5 years | −68.0% |
Signals
| 50-day / 200-day average | 0.386 / 0.318 |
|---|---|
| Golden / death cross (60 days) | Golden, 24 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.028 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 23 Jun 2023 | MYR 0.0350 |
| 16 Dec 2022 | MYR 0.0300 |
| 9 Jun 2022 | MYR 0.0300 |
| 6 Dec 2021 | MYR 0.0500 |
| 9 Sep 2021 | MYR 0.1500 |
| 24 May 2021 | MYR 0.1300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Kuala Lumpur Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.